Information about Pharmadvance
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0671.818.337

VAT liability
Yes
Established
24-02-2017
Last balance sheet year
2024
Company size
Small 3,8 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Pharmadvance

2024 2023 2022 2021
Profit/Loss 11,539 22 % 9,431 -74 % 36,257 -48 % 70,183
Equity 59,315 24 % 47,776 25 % 38,345 1736 % 2,088
Gross margin 328,716 30 % 252,392 -2 % 258,523 -25 % 344,477
Employees 3.8 3.7 4.1 3.3

Publications from Pharmadvance

Date Publication
18-07-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Goal - Resignations, Appointments (FR)
04-08-2022 Resignations, Appointments (FR)
28-02-2017 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (FR)

Frequently asked questions

What is the VAT number of Pharmadvance?
The VAT number of Pharmadvance is BE 0671.818.337.
Wat is the PEPPOL ID of Pharmadvance?
The PEPPOL ID of Pharmadvance is 0208:0671818337. Log in or start a free trial to see the full overview.
When was Pharmadvance founded?
Pharmadvance was founded on 24-02-2017.
What is the address of Pharmadvance?
The current registered office of Pharmadvance is located at Rue de l'Eglise 48, 7950 Chièvres.
When was the last time Pharmadvance filed their annual financial statements?
The most recent financial statements of Pharmadvance were filed on 26-08-2025.
How many employees does Pharmadvance have?
There are 3,8 FTEs working at Pharmadvance according to the staff figures in the most recent financial statements.
What is the annual turnover of Pharmadvance?
At the time of its most recent financial statements, Pharmadvance did not publish any turnover figures. Pharmadvance reported a gross margin of €328,716.06.